Avid Bioservices at Bioprocessing Conferences
Avid Bioservices, Inc. (NASDAQ: CDMO) is a well-respected organization in the field of biologics contract development and manufacturing. Their focus lies in delivering excellent services to firms in the biotechnology and pharmaceutical industries. With a mission directed at improving patient lives, Avid is preparing to take part in a key upcoming event—the Craig-Hallum Bioprocessing Conference. During this event, Nick Green, the president and CEO, along with Dr. Pramthesh Patel, the vice president of process development, will hold an engaging fireside chat to explore the latest strategies and advancements in the bioprocessing domain.
Details About the Craig-Hallum Bioprocessing Conference
The conference is set for September 19 and will be held virtually. Avid Bioservices will prominently showcase its leadership by participating in the fireside chat. Joining events like this allows Avid to network with industry professionals and demonstrate its dedication to advancing bioprocess innovations.
Avid's Involvement in the Conference
Here are the essential details regarding Avid's participation:
- Event: Craig-Hallum Bioprocessing Conference
- Featured Speakers: Nick Green and Dr. Pramthesh Patel
- Conference Date: September 19
- Fireside Chat Timing: 2:45 p.m. Eastern Time
- Format: Virtual
After the discussions, Avid plans to offer a recorded webcast for those unable to connect live. This way, the insights and information shared during the conference will be accessible to a broader audience.
Avid Bioservices in Biologics Development
Avid Bioservices (NASDAQ: CDMO) plays a crucial role in biotechnology, providing a wide array of services that span from early-stage process development to CGMP (current Good Manufacturing Practice) manufacturing of biologics. With over thirty years of experience, Avid specializes in essential areas like drug substance manufacturing, bulk packaging, and stability testing.
Wide Range of Services Provided by Avid
Avid offers a comprehensive suite of services, from cell line development to thorough analytics and characterization. Whether it's about tackling the complexities of new therapy development or ensuring rigorous manufacturing processes, Avid is well-equipped to meet varying client needs. This unique combination of expertise makes them an ideal partner for biotechnology companies looking to introduce innovative treatments to the market.
Future Outlook for Avid Bioservices
As biotechnology continues to progress, Avid Bioservices remains agile, ready to tackle new challenges and embrace opportunities in the industry. Participating in important events like the Craig-Hallum Bioprocessing Conference highlights Avid's involvement and positions them at the cutting edge of innovative developments in bioprocessing. Through these engagements, Avid seeks to strengthen collaborations and enhance their service offerings while keeping their primary mission of improving patient outcomes in focus.
Frequently Asked Questions
What is Avid Bioservices' primary focus?
Avid Bioservices specializes in contract development and manufacturing of biologics, with an aim to foster biological innovations that improve patient outcomes.
Who will be the main speakers at the Craig-Hallum Bioprocessing Conference?
The featured speakers at the event will be Nick Green and Dr. Pramthesh Patel.
When is the conference scheduled to happen?
The Craig-Hallum Bioprocessing Conference is set to take place on September 19.
If someone misses the live conference, how can they access the discussions?
A webcast replay will be posted on Avid’s investor website following the conference.
What other services does Avid Bioservices provide?
Avid offers a diverse range of services, including process development, clinical and commercial manufacturing, bulk packaging, testing services, and support for regulatory submissions.
